Literature DB >> 33408068

Covid-19 vaccination: What's the evidence for extending the dosing interval?

Gareth Iacobucci1, Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2021        PMID： 33408068     DOI： 10.1136/bmj.n18

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.

Authors:  Santiago Romero-Brufau; Ayush Chopra; Alex J Ryu; Esma Gel; Ramesh Raskar; Walter Kremers; Karen S Anderson; Jayakumar Subramanian; Balaji Krishnamurthy; Abhishek Singh; Kalyan Pasupathy; Yue Dong; John C O'Horo; Walter R Wilson; Oscar Mitchell; Thomas C Kingsley
Journal:  BMJ       Date:  2021-05-12

2.  How the COVID 19 pandemic will shape influenza public health initiatives: The UK experience.

Authors:  Mansoor Ashraf; Sankarasubramanian Rajaram; Peter M English
Journal:  Hum Vaccin Immunother       Date:  2022-04-18       Impact factor: 4.526

3.  Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.

Authors:  Chadi M Saad-Roy; Sinead E Morris; C Jessica E Metcalf; Michael J Mina; Rachel E Baker; Jeremy Farrar; Edward C Holmes; Oliver G Pybus; Andrea L Graham; Simon A Levin; Bryan T Grenfell; Caroline E Wagner
Journal:  medRxiv       Date:  2021-02-03

4.  Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine.

Authors:  Mark A Brockman; Francis Mwimanzi; Yurou Sang; Kurtis Ng; Olga Agafitei; Siobhan Ennis; Hope Lapointe; Landon Young; Gisele Umviligihozo; Laura Burns; Chanson Brumme; Victor Leung; Julio S G Montaner; Daniel Holmes; Mari DeMarco; Janet Simons; Masa Niikura; Ralph Pantophlet; Marc G Romney; Zabrina L Brumme
Journal:  medRxiv       Date:  2021-03-24

Review 5.  Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021.

Authors:  Chang-Jie Cheng; Chun-Yi Lu; Ya-Hui Chang; Yu Sun; Hai-Jui Chu; Chun-Yu Lee; Chang-Hsiu Liu; Cheng-Huai Lin; Chien-Jung Lu; Chung-Yi Li
Journal:  Vaccines (Basel)       Date:  2021-12-16

6.  Modelling policy combinations of vaccination and transmission suppression of SARS-CoV-2 in Rio de Janeiro, Brazil.

Authors:  Naiara C M Valiati; Daniel A M Villela
Journal:  Infect Dis Model       Date:  2021-12-31

7.  Inhibition of receptor-binding domain-ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS-CoV-2 vaccines.

Authors:  Valéria O Silva; Rosemeire Yamashiro; Cintia M Ahagon; Ivana B de Campos; Isabela P de Oliveira; Elaine L de Oliveira; Giselle I S López-Lopes; Elaine M Matsuda; Marcia J Castejon; Luís F de Macedo Brígido
Journal:  J Med Virol       Date:  2021-10-20       Impact factor: 20.693

8.  Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province.

Authors:  Maria Elena Flacco; Graziella Soldato; Cecilia Acuti Martellucci; Roberto Carota; Rossano Di Luzio; Antonio Caponetti; Lamberto Manzoli
Journal:  Vaccines (Basel)       Date:  2021-06-10

9.  Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants.

Authors:  Ruiqi Zhang; Danlei Liu; Ka-Yi Leung; Yujing Fan; Lu Lu; Pui-Chun Chan; Kelvin Kai-Wang To; Honglin Chen; Kwok-Yung Yuen; Kwok-Hung Chan; Ivan Fan-Ngai Hung
Journal:  Vaccines (Basel)       Date:  2022-01-03

10.  Application of quantitative systems pharmacology to guide the optimal dosing of COVID-19 vaccines.

Authors:  Mario Giorgi; Rajat Desikan; Piet H van der Graaf; Andrzej M Kierzek
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.